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Interleukin-7 (IL7) is a hematopoietic cytokine with critical functions in both B- and T-lymphocyte development. In this
study, we ®nd that IL7 exhibits trophic properties in the developing brain as well. Treatment of cultures of embryonic
brain with exogenous IL7 increases neuronal survival and results in greater numbers of cells manifesting neurite outgrowth.
As demonstrated with single-cell cultures, IL7 acts directly to promote neuronal survival. Expression of the mRNA encoding
the high-af®nity IL7 receptor (IL7R) is observed in vitro in neurons as well as in subventricular zone progenitor cells.
Phosphorylation of p59fyn, which is activated by IL7 in pre-B cells and is thought to be important in neural development,
occurs rapidly following IL7 treatment of cultured embryonic neurons. Additionally, the expression of c-myc mRNA, which
is modulated by IL7 in lymphoid cells, is upregulated by IL7 in the same CNS cultures. Finally, the messenger RNAs
encoding IL7 and IL7R are expressed in vivo in developing brain. The direct neurotrophic properties of IL7 combined with
the expression of ligand and receptor in developing brain suggest that IL7 may be a neuronal growth factor of physiological
signi®cance during central nervous system (CNS) ontogeny. q 1996 Academic Press, Inc.
INTRODUCTION A large number of cytokines, including the interleukins,
colony stimulating factors, interferons, and others, have
been identi®ed in immune development, and a subset of
The developing immune and nervous systems are charac- these may be involved in neural development as well (Pat-
terized by many common features. In hematopoietic devel- terson and Nawa, 1993; Mehler and Kessler, 1994). One
opment, the choices of lineage commitment are in¯uenced such hematopoietic factor is IL7, which was initially char-
to a great extent by signals in the extracellular environment, acterized as a growth factor for B cell precursors (Namen et
and similar mechanisms appear to operate in neuropoiesis. al., 1988). Subsequently, IL7 was found to be trophic for
The neurotrophin family, consisting of nerve growth factor populations of precursor and mature T cells (Watson et al.,
(NGF) and related trophic factors, have been clearly impli- 1989; Conlon et al., 1989) and for cells of the myeloid lin-
cated in peripheral nervous system development. A long eage, including monocytes and eosinophils (Vellenga et al.,
history of evidence supporting their role in ontogeny culmi- 1992; Alderson et al., 1991). The importance of IL7 in hema-
nated in the neurotrophin and trk gene deletion studies in tolymphopoiesis has been con®rmed by the severe reduc-
mice, which unequivocally established the importance of tion in both B and T lymphocytes seen in IL7 or IL7R-
this family in the normal development of the peripheral de®cient mice (Grabstein et al., 1993; Sudo et al., 1993;
nervous system (reviewed in Snider, 1994). However, a Peschon et al., 1994; Bhatia et al., 1995; von Freeden-Jeffry
striking ®nding of the targeted deletion studies was the rela- et al., 1995).
tive lack of abnormalities in the central nervous system. A receptor complex which includes the high-af®nity IL7
Histological examination reveals few gross abnormalities receptor (IL7R) is responsible for mediating the effects of IL7
in CNS structures in these mutant mice, in contrast to the (Goodwin et al., 1990). The gc subunit, previously known as
dramatic abnormalities observed peripherally. It is therefore the IL2Rg subunit, was identi®ed as an additional subunit
likely that other growth factors are important for the nor- of the IL7 receptor (Kondo et al., 1993; Noguchi et al., 1993;
mal development of the CNS and, further, that CNS popula- Russell et al., 1993). The IL7 receptor complex signals
tions are not reliant upon a single trophic factor for develop- through cytoplasmic tyrosine kinases, including p59fyn and
p53/56lyn, members of the src family of kinases, and Jak1mental survival.
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poly-D-lysine or laminin-coated 24-well plates in serum-free me-and Jak3, members of the Janus family of kinases (Venkitar-
dium without EGF. mRNA was harvested from spheres or platesaman and Cowling, 1992; Seckinger and Fougereau, 1994;
as described below.Kirken et al., 1994; Russell et al., 1994; Miyazaki et al.,
Immunochemistry. Immunostaining was performed as pre-1994). The expression and function of some of these kinases,
viously described (Mehler et al., 1993). Cells were ®xed in coldnotably p59fyn, have been studied in the CNS (Grant et al.,
100% methanol or 4% (w/v) paraformaldehyde, blocked with 5%
1992; Maness, 1992; Yagi et al., 1993; Umemori et al., 1994; normal goat serum for 30 min at room temperature, and incubated
Ignelzi et al., 1994); however, expression and function of overnight with primary antibody at 47C. The following day, incuba-
IL7 and IL7R in brain has not been demonstrated. tion with biotinylated secondary antibody from the ABC kit (Vector
Previous studies have revealed that IL7 promotes neu- Labs) was carried out for 30 min at room temperature. Wells were
ronal differentiation of conditionally immortalized hippo- then incubated with ABC reagent for 1 hr at room temperature.
campal progenitor cells (Mehler et al., 1993; Rozental et al., Binding was visualized using 0.5 mg/ml of diaminobenzidine
(Sigma) (in 0.01% hydrogen peroxide, 50 mM Tris±Cl, 0.14 M NaCl,1995). Further, IL7 was shown to have neurotrophic activity
pH 7.4), and staining was analyzed by light microscopy. SMI31in primary hippocampal cultures (Araujo and Cotman,
antibody to the mature 200-kDa phosphorylated form of neuro®l-1993). This study focuses on de®ning the cellular targets
ament was purchased from Sternberger Monoclonals, Inc.for IL7 in developing brain, the neural actions of the cyto-
Reverse transcription-polymerase chain reaction (RT-PCR).kine, and its potential role as a neurotrophic factor. We ®nd
RNA was isolated from tissue or cells by the single-step guanidi-that IL7 acts directly on neurons cultured from embryonic
nium thiocyanate method (Chomczynski, 1993) using TRI RE-
brain regions to enhance survival and neurite outgrowth, AGENT (Molecular Research Center), quantitated by absorbance
to stimulate p59fyn phosphorylation, and to upregulate c- at 260 nm, and digested with RQ1 RNase-free DNase (1 U/ml; Pro-
myc expression. The mRNA encoding IL7R is appropriately mega). Reverse transcription and PCR were performed using the
expressed in vitro by neurons as well as by subventricular SuperScript preampli®cation system (Gibco) according to the man-
zone neural progenitor cells. Additionally, IL7 and IL7R ufacturer's instructions. Brie¯y, 2 mg of total RNA were reverse
transcribed for 60 min at 427C followed by a 15-min inactivationmRNA expression are detected in vivo in developing and
at 707C. Next, oligonucleotide primers were added to a ®nal con-adult brain. These data suggest that IL7 is a neurotrophic
centration of 0.5 mM along with 2.5 units of Taq Polymerase (Boeh-factor of potential physiological signi®cance during brain
ringer Mannheim). PCR cycles consisted of denaturation at 947Cdevelopment.
for 2 min, reannealing at 65±707C for 1 min, and extension at 727C
for 3 min. Up to 40 cycles of PCR were run for IL7, 35 for IL7R,
and 25 for actin. Oligonucleotide primers used were the following:
MATERIALS AND METHODS IL7 (nucleotides 1982±2005 and 2364*±2341 (Lupton et al., 1990),
which ampli®ed a 290-bp segment; IL7R (nucleotides 921±941 and
1341*±1321 (Goodwin et al., 1990)), which ampli®ed a 420-bp frag-Tissue culture. Embryonic Day 17 Sprague±Dawley rats were
ment; and actin (Ross et al., 1992), which ampli®ed a 350-bp frag-sacri®ced and brain regions immediately removed by dissection.
ment. Southern analysis was performed for IL7 with a random-The various regions, including hippocampus, striatum, cerebellum,
primed probe from the IL7 cDNA insert described below.cortex, and hypothalamus, were incubated in trypsin at 377C for
RT-PCR was performed to maximize qualitative yield, and not15 min and then mechanically dissociated. Twenty-four-well plates
in a strictly quantitative manner. Thus, larger cycle numbers werewere coated with 50 mg/ml poly-D-lysine, and the cells plated in
used in the PCR reactions for greater sensitivity. Nevertheless,serum-free DME medium were supplemented with B-27 additives
equal amounts of RNA from the same tissue samples were assayed(Gibco, Grand Island, NY), at an initial density of 104 cells/well.
for expression of actin mRNA to verify that comparable levels ofMurine IL7 was generously supplied by Genetics Institute. Results
RNA were present in all samples. Numerous repetitions of eachwere con®rmed with recombinant murine IL7 (rmIL7; R & D). On
experiment on different RNA samples gave consistent semiquanti-each day after plating, cultures were evaluated for survival and
tative results.process outgrowth (greater than 1.5 somatic diameters). Cell counts
Solution hybridization assays. The procedures followed werewere made from 0.5-mm2 representative areas of each well.
those described in the Ambion RPA II kit manual. Brie¯y, 10±To prepare high density cultures, E16 mouse cortex was dissected
25 mg of RNA were coprecipitated with 104±105 cpm of antisensein the same fashion and plated on poly-D-lysine-coated 60-mm
riboprobe, and incubated overnight at 427C in hybridization buffer.dishes at a density of 5 1 106 cells/dish. After 2 days, cells were
Following hybridization, samples were digested with a combina-treated with 20 ng/ml of rmIL7 (R & D) and then harvested for
tion of RNase A/T1 for 30 min at 377C, and electrophoresed on 5%RNA or protein.
polyacrylamide gels for 2.5 hr at 250 V. The dried gels were exposedAstrocytes were cultured as previously described (Batter and Kes-
to Kodak X-Omat ®lm for 1 (actin, L-myc, N-myc) or 7 days (IL7)sler, 1991). The exact cellular composition of cultures prepared in
at 0757C.this fashion was characterized immunocytochemically in a previ-
As a negative control in each experiment, one hybridization mixous study (Vilijn et al., 1988).
contained yeast tRNA alone, and no protected species were seenEGF-generated subventricular zone progenitor cultures were es-
in these samples. Occasionally, a faint band was seen in these andtablished according to the method previously described (Reynolds
other samples at the level of full-length probe. A small sample ofand Weiss, 1992). Brie¯y, striatal dissections of E17 mice were
undigested full-length probe was run on each gel to distinguishperformed, cells mechanically dissociated, and cultured in ¯asks
between undigested probe and protected species. Protected specieswith N2 medium supplemented with 25 ng/ml EGF. Spheres were
in digested samples were smaller than undigested plasmid, due tocollected after 7 days, dissociated, and replated in EGF-containing
medium. After 7 days, spheres were dissociated and plated into small stretches of plasmid sequences in the probe which were not
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protected from RNase digestion. b-Actin probe was included in the
same hybridization mixes as the N-myc or IL7 probes.
Riboprobe construction. A 340-bp XhoI/ClaI fragment of the
IL7 cDNA was subcloned into pGEM7ZF (Promega) for use as tem-
plate in an antisense riboprobe labeling reaction. The plasmid was
linearized using BamHI to generate a 390-bp full-length probe. A
560-bp ClaI/PstI fragment of N-myc in Sp64 was linearized with
EcoRI, and for L-myc, a 180-bp PstI fragment in pT7T3a-19 was
linearized with EcoRI. The vectors containing c-myc, L-myc, and
N-myc were generously provided by Drs. N. Schreiber-Agus and R.
DePinho.
After linearization, 1.0 mg of template DNA was used in the
riboprobe reaction with 8 ml of [32P]rUTP (3000 Ci/mmol; NEN)
and 2 ml of either T7 or SP6 RNA Polymerase (Promega). Transcrip-
tion was terminated by addition of 10 units of RNase-free DNase
(Boehringer Mannheim). An equivalent volume of gel-loading
buffer (Ambion) was then added to the reaction, followed by boiling
3±4 min at 957C. The entire sample was loaded on an 8 M urea
denaturing polyacrylamide gel and electrophoresed for 2 hr at 250
V. The region of the gel containing full-length riboprobe was ex-
cised and incubated in elution buffer (Ambion) overnight at 377C.
For construction of actin riboprobe, template from the RPA II
kit (Ambion, Austin, TX), was used. Similar transcription condi-
tions were used, except that 1 ml of [32P]rUTP was added and cold
rUTP was added to 10 mM. T3 RNA Polymerase was used to synthe-
size a full-length probe of approximately 300 bp, with a protected
species of 250 bp. FIG. 1. (a) Dose±response analysis of IL7 effect on hippocampal
Northern blotting. RNA, 10±20 mg for each sample, was loaded cultures. Cells dissociated from E17 rat hippocampus were plated
on a 1% agarose/formaldehyde gel. Ethidium bromide was included in 24-well dishes and treated with indicated doses of IL7. Cell
in each sample to visualize 28S and 18S RNA and verify equal counts from representative 0.5-mm2 areas 3 days after plating were
sample loading. The 0.24- to 9.5-kb RNA ladder was used (Gibco). graphed. Dose±responses are shown for both total cell number and
Following electrophoresis and photography, the gel was blotted process-bearing cell number. This experiment was repeated twice.
onto GeneScreen Plus according to the manufacturer's instructions (b) Effect of IL7 on cell adhesion. Cells were plated in the absence
(Dupont). Random-primed probe was prepared from a 750-bp XbaI/ of presence of IL7 and analyzed by light microscopy after 6 hr. No
SacI c-myc fragment from exon 2 cloned into Bluescript KS/ (Stra- difference in either cell number or process extension was found
tagene) using the Prime-It II kit (Stratagene). For hybridization, 5 between control and treated cultures. (2001 magni®cation)1 105 cpm/ml buffer was added. Following washing, blots were
exposed to Kodak X-Omat ®lm.
Immunoprecipitation and immunoblotting. High density cor-
tical cultures treated with IL7 for 0±15 min were rinsed with PBS,
that IL7 in particular markedly enhanced cell survival, andand proteins solubilized with lysis buffer (1.0% Triton X-100, 150
more detailed studies were thus undertaken. Dose±re-mM NaCl, 50 mM Tris, 1 mM EDTA, 100 mM sodium vanadate, 1
sponse analysis indicated maximal effect of IL7 on cell sur-mM PMSF, 100 mg/ml aprotinin, pH 7.5) at 47C for 30 min. Proteins
were quantitated with the Bio-Rad (Bradford) protein assay and then vival at 10 U/ml, with EC50 between 0.1 and 1.0 U/ml (Fig.
immunoprecipitated with human anti-p59fyn (UBI) according to the 1a). To ensure that the effect of IL7 was not due to improved
manufacturer's instructions. Following 10% SDS/PAGE, proteins adhesion, cells were examined at 6 hr after plating, and no
were transferred to nitrocellulose and phosphotyrosine-containing difference in cell number or process extension was observed
proteins detected with the Biotin-enhanced Western blotting kit, between control and IL7-treated cultures (Fig. 1b).
Alk. Phos. (UBI). The alkaline phosphatase reaction in BCIP/NBT We next asked whether IL7 trophism was restricted to
proceeded for 2±3 hr before the blot was dried and photographed.
hippocampus or whether neural cells from other brain re-
gions might similarly respond to exogenous IL7. Cultures
were therefore established in serum-free medium from ®veRESULTS
discrete regions of E17 rat brainÐhippocampus, striatum,
cerebellum, cortex, and hypothalamus. IL7 signi®cantly en-Effect of IL7 on Primary CNS Cultures hanced survival in all regions as compared to control cul-
tures (Fig. 2). Maximal survival as determined by dose±re-Because IL7 has been shown to induce neuronal differenti-
ation of immortalized neural cells (Mehler et al., 1993), it sponse analysis was obtained with doses ranging from 1.0
to 20.0 U/ml, depending on the region. In order to standard-was of interest to determine whether neurotrophic effects
might be observed in primary neural cultures. Preliminary ize for regional comparison, a dose of 10.0 U/ml was used
in all experiments shown in Fig. 2. The relative increasesstudies which tested the effects of a number of different
cytokines on embryonic hippocampal cultures indicated in total cell number were apparent within 24 hr. Although
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FIG. 2. Effect of IL7 on cell number and process outgrowth in CNS primary cultures. Five regions from E17 rat brain were dissected,
plated in 24-well dishes, and treated at the time of plating with 10.0 U/ml IL7. Cells were grown in serum-free medium for 5 days, and
representative 0.5-mm2 areas were counted on each day. The top graph in each shows total number of cells in a representative area plotted
vs days in culture. The bottom graphs show number of cells exhibiting processes (1.5 somatic diameters) plotted vs days in culture. IL7
increased cell numbers and process-containing cells compared to untreated cultures in each region. Bars represent mean cell number {
SEM. Each analysis was performed in triplicate 5 times.
cell numbers gradually decreased over a 5-day time course number was rapid and long-lasting. The same was true in
the four other regions examined.in treated as well as control cultures, the ratio of cells in
treated vs control cultures actually increased with time. Additionally, an increase in the number of cells bearing
processes was observed in response to IL7 (Fig. 2). ControlFor example, in hippocampus, the average cell number of
representative areas in IL7-treated cultures was 215 { 17.0 cultures contained a small number of cells with processes,
and this number declined continuously over the ensuing 5compared to 58 { 6.2 in untreated cultures on Day 1, a 3.7-
fold difference. By Day 5, treated cultures had 142 { 9.3 days. The percentage of cells with processes was generally
under 50%, and often considerably lower. In contrast, IL7-cells in representative areas compared to 21{ 1.9 in control
cultures, a 6.8-fold difference. Thus, the effect of IL7 on cell treated cultures displayed a signi®cantly larger number of
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FIG. 3. Neuro®lament staining of IL7-treated cultures. Three brain regions as indicated were dissected from E17 rat brain and plated on
poly-D-lysine-coated coverslips. Cultures were grown for 4 days in serum-free medium in the presence or absence of IL7 and then ®xed
and stained for NF200. An increase in neuronal number and neurite outgrowth was observed in each region in response to IL7. Each panel
represents 2001 magni®cation.
process-bearing cells. The percentage of cells with processes for NF200. Thus, the increase in cell number after IL7 treat-
ment re¯ected an increase in the number of neurons, andexceeded 50% by Day 1 or 2 in all regions, and on Day 5
ranged from 66 to 94%, depending on the region. the increased percentage of process-bearing cells re¯ected
an increased proportion of neuronal cells exhibiting neuriteMorphological examination of the cultures suggested that
most cells in IL7-treated cultures were neurons. To con®rm outgrowth.
this, cells were immunostained with an antibody to the
200-kDa phosphorylated form of neuro®lament (NF200) 4
IL7 Exerts Direct Trophic Actions on Neuronsdays after treatment (Fig. 3). Neuro®lament staining was
rare in control cultures, although occasional positive cells These experimental observations suggested that IL7 treat-
ment is neurotrophic, but did not distinguish between awere seen, particularly in cortex. However, in IL7-treated
cultures, most cell bodies and processes stained positively direct effect on neurons or a secondary effect mediated by
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TABLE 1
Effect of IL7 Treatment of Single Cell Cultures from Brain Regions
Single-cell cultures
Total number of single cells plated Total number of cells Total number of cells Neuro®lament/ cells
at Day 0 at Day 1 at Day 4 at Day 4
Hippocampus
Control 22 1 0 Ð
IL-7 treated 25 23 16 6
Striatum
Control 26 3 0 Ð
IL-7 treated 24 22 15 ND
Cortex
Control 24 2 0 Ð
IL-7 treated 23 19 5 ND
Note. Cultures were established from embryonic rat hippocampus, striatum, and cortex and treated at the time of plating with 20 ng/
ml of IL7. Untreated cells rapidly died, with no survival after Day 1. IL7-treated cells from hippocampus and striatum exhibited good
survival, and some survival was seen in cells from cortex. Hippocampal cells were ®xed on Day 4 and subsequently stained for NF200.
6/16 surviving cells stained positively, indicating that IL7 directly supported the survival of neurons. ND, not determined.
nonneuronal cells. To address this issue, single-cell analysis neuronally enriched hippocampal cultures did contain IL7R
mRNA. Thus, in vitro, astrocytic cultures synthesizedwas performed. Individual cells were plated in wells, such
that no more than one cell was present in any well. The mRNA encoding the ligand and not the receptor, whereas
neuronal cultures expressed IL7R.results of a representative experiment are shown in Table
1. The cells were assessed for survival 1 day after plating. The expression of IL7R by neural progenitor cells from
developing generative zones was also examined. Cells wereIn single-cell conditions, virtually all cells in control cul-
tures died within 24 hr (Table 1). In contrast, the majority isolated from the subventricular zone of neonatal mice as
described previously (Reynolds and Weiss, 1992), allowedof individual cells treated with IL7 survived for 24 hr, and
on Day 4, a signi®cant number were still viable. No more to form proliferating neurospheres in the presence of epider-
mal growth factor (EGF), subcloned, and propagated asthan one cell was ever observed in a well, indicating that
IL7 did not induce proliferation in this paradigm. Surviving monolayers on laminin-coated dishes in serum-free, EGF-
free medium. RNA harvested from the monolayer culturescells from hippocampus were stained for NF200 on Day 4,
and 6/16 were positive. Thus, IL7 directly supported the contained mRNA encoding IL7R, with no obvious change
in levels of expression after 2±5 days of IL7 treatment, assurvival of cells whose neuronal identity was con®rmed by
neuro®lament immunocytochemistry. The remaining sur- determined by RT-PCR analysis (Fig. 4b). Spheres grown in
suspension with EGF and without IL7 similarly expressedviving cells may have been nonneuronal cells, precursors,
or alternatively, neurons which had not yet expressed sig- IL7R mRNA. Thus, progenitor cells cultured from the de-
veloping CNS, as well as neurons cultured from brain, ex-ni®cant amounts of NF200.
pressed mRNA encoding the high af®nity IL7R, consistent
with the effects of IL7 treatment on each set of cultures.
Cell Types Which Express IL7 and Its Receptor These ®ndings imply that IL7 could act on early stages of
neuronal lineage elaboration.
To determine which cells synthesize IL7 and IL7R mRNA
in brain, cultured astrocytes from four regions of rat brain
were analyzed for expression of IL7 and IL7R mRNA by IL7 Induction of p59fyn Phosphorylation
RT-PCR (Fig. 4a). Astrocytes from hippocampus, striatum,
cerebellum, and cortex all expressed IL7 mRNA. The levels Since p59fyn undergoes phosphorylation in response to IL7
treatment in lymphocytes (Venkitaraman and Cowling,of IL7 mRNA in astrocytes differed among regions, whereas
the levels of actin were essentially the same. Nuclease pro- 1992; Seckinger and Fougereau, 1994), we studied the effect
of IL7 on p59fyn phosphorylation in cortical neurons. Cul-tection analysis con®rmed the expression of IL7 mRNA in
cortical astrocytes (Fig. 7b). Cultures grown in serum-free tures from E16 mouse cortex were grown at high density
in serum-free medium such that excellent survival was ob-medium to enrich for neurons contained IL7 mRNA as well,
as demonstrated by RT-PCR (Fig. 4a) and nuclease protec- served in the absence of exogenous factors. These cultures
consisted of 97% neurons based on neuro®lament immu-tion analysis (Fig. 7b). In contrast, IL7R mRNA was not
ampli®ed from astrocytic cultures by RT-PCR, whereas nocytochemistry (unpublished observations). After 2 days
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FIG. 4. Expression of IL7 and IL7R in neural cells in vitro. (a) RT-PCR analysis of RNA isolated from the indicated cultured cells.
Astrocytes were cultured from four different regions of rat brain as indicated. Hippocampal cultures were grown in serum-free medium
in the presence of B-27 to enrich for neurons. IL7 mRNA was expressed in astrocytic and neuronal cultures, whereas IL7R mRNA was
detected only in neuronal cultures. Actin was expressed uniformly in all cultures. (b) Expression of IL7R by subventricular zone progenitor
cells. RT-PCR analysis demonstrates expression of IL7R mRNA in progenitor cells grown on laminin-coated dishes (Lm) for 0, 2, or 5
days of IL7 treatment. Cells grown in spheres (Sph) also expressed IL7R mRNA. Thy-adult thymus; tRNA-yeast tRNA. 35 cycles of PCR
were performed for IL7R, 20 for actin. Following PCR, a sample of each reaction was run on a 1.5% agarose gel which was then stained
with ethidium bromide and photographed. Each experiment was performed twice.
in culture, cells were treated with 20 ng/ml of rmIL7 for 0± ticular stages of brain development (DePinho et al., 1991).
The possible regulation of myc genes by IL7 in developing15 min. Following lysis, protein extracts were subjected to
immunoprecipitation with anti-p59fyn. Subsequent Western CNS is therefore of interest as well. Cortical cultures were
again grown at high density for 2 days, treated brie¯y withanalysis with antiphosphotyrosine revealed that p59fyn was
phosphorylated within 5 min of IL7 treatment (Fig. 5), indi- 20 ng/ml rmIL7 for the indicated times, and then harvested
for RNA. Expression of c-myc was studied by Northerncating that the transduction pathway of IL7 in neurons in-
volves some of the same elements used in lymphoid cells. analysis and found to rapidly increase in response to IL7
(Fig. 6a). Expression of N-myc and L-myc was examined by
nuclease protection analysis, and no change in response to
Upregulation of c-myc by IL7 IL7 was observed (Fig. 6b). However, levels of both N- and
L-myc were consistently high, as might be expected for aTo investigate whether IL7 can regulate short-term neu-
ronal gene expression, we examined effects on expression population of differentiating neurons, and this may have
masked any potential IL7 effect. The rapid regulation of c-of myc family genes. IL7 regulates transcription of the c-
myc gene in pre-B and T cell lines and N-myc expression myc expression by IL7 in high-density cultures demon-
strates that IL7 has short-term effects on primary culturesin pre-B, but not mature B or T cells (Morrow et al., 1992;
Yip-Schneider et al., 1993; Seckinger et al., 1994). L-, N-, which can be observed independent of long-term survival
effects.and c-myc are all expressed at relatively high levels at par-
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sults quantitatively con®rmed the RT-PCR results demon-
strating expression of IL7 mRNA from embryonic to adult
brain.
mRNA encoding the high-af®nity IL7 receptor was also
detected in brain (Fig. 7c). Expression was noted as early as
Embryonic Day 16 by RT-PCR, continued through develop-
ment, and was noted in adult brain as well. The ®gure shows
the results of 35 cycles of PCR for IL7R; however, intense
bands, such as P15 brain, were clearly visible after 30 cycles
of PCR. The identity of PCR products was con®rmed by
sequencing and by Southern analysis. This initial, qualita-
tive demonstration of ligand as well as receptor expression
in brain development provides an important framework for
FIG. 5. Phosphorylation of p59fyn following IL7 treatment of corti- a postulated physiologic role of IL7.
cal neurons. High density cultures were treated with 20 ng/ml
rmIL7 for 0±15 min and proteins were isolated. Following immuno-
precipitation with an antibody to p59fyn, the antigen±antibody
DISCUSSIONcomplexes were dissociated in Laemmli buffer. Samples were ana-
lyzed by SDS±PAGE and immunoblotting with an anti-phosphotyr-
In this study, we have demonstrated that the hematopoi-osine antibody. Whereas no phosphorylation of p59fyn was observed
in the absence of IL7, phosphorylation was seen following 5 min etic cytokine IL7 may be a neuropoietic growth factor as
of IL7 treatment and persisted for at least 15 min. 500 mg of protein well. Two complementary strategies were employed to ar-
were used in each immunoprecipitation reaction. The experiment rive at this conclusion. The ®rst was investigation of the
was repeated twice with identical ®ndings. effects of IL7 in vitro on primary brain cultures. IL7 was
found to exert direct trophic effects on cells cultured from
the developing CNS, including neurons. The second was
examination of IL7 and IL7R expression in brain develop-
Developmental Expression of IL7 and IL7R in Vivo ment; both ligand and receptor are expressed in vivo and in
vitro in developing mouse brain.To address the question of whether IL7 is expressed in
vivo in the developing CNS, we ®rst employed 30- and 40- IL7 increased survival, as well as numbers of cells ex-
tending processes, from ®ve different embryonic brain re-cycle RT-PCR analysis of RNA extracts from mouse brain
at various developmental ages. IL7 mRNA expression was gions. Neuro®lament staining con®rmed that neuronal
number was greater in IL7-treated cultures. Although thedetected in whole brain from Embryonic Day 17 and contin-
ued through the postnatal period into adulthood (Fig. 7a). cultures were grown in conditions which enriched for neu-
rons, these observations did not rule out an indirect effectSpeci®c brain regions, including developing cerebellum and
hippocampus, also manifested mRNA encoding IL7 after mediated by the small nonneuronal population. Multiple
cytokines have been suggested to act upon CNS nonneu-30 cycles, with expression in certain regions such as adult
hippocampus becoming evident only following 40 cycles. ronal cells in vitro, including the hematopoietic cytokines
IL4, IL5, IL7, and IL8 (Araujo and Cotman, 1993); and manyExpression of IL7 was not detected in adult cerebellum,
even after 40 cycles. Expression of IL7 mRNA in whole cytokines are secreted by cultured nonneuronal cells, in-
cluding IL-1, IL-3, G-CSF, M-CSF, GM-CSF, TNFa, IL-6, IL-brain was noted as early as Embryonic Day 13 (unpublished
observations). Although PCR was not performed in a strictly 8, and others (Giulian and Baker, 1986; Righi et al., 1989;
Malipiero et al., 1990; Aloisi et al., 1992). Indirect neuronalquantitative fashion, it appeared that IL7 mRNA levels were
somewhat higher in developing than in adult brain. Addi- effects of cytokines mediated by nonneuronal cells are well
described. For example, interferon treatment of culturedtional analysis is required to precisely de®ne temporal pat-
terns in speci®c regions. basal forebrain regulates cholinergic gene expression indi-
rectly via effects on microglia (Jonakait et al., 1994). Thus,Quantitative nuclease protection analysis was performed
in poly(A)/ RNA extracts from mouse brains of four differ- given the many known interactions of cytokines with glial
cells, it was critical to determine whether IL7 acted directlyent ages to con®rm IL7 expression (Fig. 7b). After RNase
digestion, the protected species of 340 basepairs was ob- upon neurons.
Araujo and Cotman have suggested that IL7 acts indi-served in E16, neonatal, Postnatal Day 18, and adult brain,
and exactly comigrated with the band in the thymus posi- rectly on neurons, since they found an increase in glial cells,
in addition to neurons, following IL7 treatment (Araujo andtive control. As an internal standard, a murine actin probe
was added to the tissue hybridization mixes and correspond- Cotman, 1993); however, their cultures were grown in se-
rum-containing medium, which permits glial survival,ing signal was observable in each expected lane. Yeast tRNA
was used as a negative control and did not protect IL7 or whereas our cultures were grown in serum-free medium
to enrich for a neuronal population. To address this issueactin. Astrocyte cultures from cortex and neuronal-enriched
cortical cultures contained IL7 mRNA as well. These re- conclusively, we employed single-cell cultures. Individual
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FIG. 6. Regulation of myc gene expression in IL7-treated cortical cultures. Cultures were established from E16 mouse cortex and grown
at high density in serum-free medium. Cells were treated with 20 ng/ml rmIL7 for the indicated times in minutes and harvested immediately
for RNA. (a) 20 mg of each sample was analyzed by Northern blotting and hybridization with a c-myc probe. Expression of c-myc was
upregulated within 15 min and began decreasing after 60±120 min. This experiment was repeated three times with similar results. The
0-min lane refers to a control sample treated with vehicle for 60 min and harvested concomitantly with the treated samples. Ethidium
bromide staining of 28S and 18S RNA veri®ed equal loading in each experimental lane. A 1-day exposure is shown. (b) 10 mg of each
sample were analyzed by nuclease protection assay for expression of N-myc and L-myc mRNA. High levels of expression of each were
observed throughout the time course, with no obvious change in response to IL7. Actin probe was included in the same samples as N-
myc probe, while L-myc probe was incubated with separate but equal volume samples. A 1-day exposure is shown.
cells were plated in serum-free medium, and survival was these data suggest a model in which IL7 is synthesized by
nonneuronal cells, particularly astrocytes, and exerts neuro-assessed in the presence or absence of IL7. In the absence
of added cytokines, cellular survival was poor; addition of trophic activity on IL7 receptor-containing neurons; this
population of responsive neurons can be supported in vitroIL7 signi®cantly enhanced cellular and neuronal survival.
On Day 4, individual cells were stained for neuro®lament, by exogenously added IL7, as seen in single-cell cultures.
An important determinant of IL7 trophism was the ageand positive staining was seen in a number of wells without
evidence of cellular proliferation. These observations dem- of the embryos used to establish the primary cultures. Neu-
rons cultured from younger embryos generally respondedonstrated unequivocally that IL7 directly enhanced neu-
ronal survival. The cells surviving in the other wells may more robustly to IL7 than those from older embryos. Em-
bryos older than E17 (E16 in mice) did not exhibit signi®-have been nonneuronal cells or, alternatively, less mature
precursors which did not yet express the 200-kDa phosphor- cant IL7 responses (unpublished observations). Thus, IL7
ostensibly exerts its effects early in development. Addition-ylated form of neuro®lament.
IL7 receptor mRNA was expressed in neuronal but not ally, RNA isolated from subventricular zone progenitor
cells grown in spheres or in monolayer cultures containedastrocytic cultures, further supporting the thesis that IL7
acts directly on neurons. In contrast, IL7 mRNA was de- IL7R mRNA, further pointing to a role for IL7 early in neu-
ropoietic development.tected in both astrocytic and neuronal-enriched cultures.
These expression studies were performed on cultured cells, The exact nature of the trophic effect of IL7 is not entirely
clear. It is unlikely that IL7 acted as a mitogenic factor,and thus no de®nitive conclusion can be drawn about in
vivo cell-type expression, although both the cytokine and since cell number steadily decreased even in treated cul-
tures, albeit at a much slower rate than in untreated cul-its receptor are expressed in vivo (Fig. 7). Nevertheless,
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FIG. 7. Expression of IL7 and IL7R mRNA in vivo in developing brain. (a) RT-PCR analysis of tissue RNA samples for IL7 mRNA
expression. Following 30 (upper gel) and 40 (lower gel) cycles of PCR, a sample of each reaction was run on a 1.5% agarose gel and stained
with ethidium bromide. Samples from both whole brain extracts and speci®c regional extracts were assayed for IL7 expression. Neonatal
thymus was used as a positive control and yeast tRNA as a negative control. IL7 mRNA was detected in thymus and multiple brain
samples following 30 cycles, and in additional samples including adult kidney, adult brain, and adult hippocampus following 40 cycles.
E, embryonic day; P, postnatal day. (b) Nuclease protection analysis of 10 mg of Poly(A)/ from mouse whole brain of four different ages
for IL7 mRNA, with actin signal shown below. Total RNA samples from cultured cortical astrocytes and neurons also were examined
for IL7 mRNA expression. A 1-week exposure is shown for IL7 and a 1-day exposure for actin. (c) Analysis of brain samples for IL7 receptor
by RT-PCR demonstrates expression at E13, increasing throughout development to a maximum at P15. Thy, adult thymus; E13, E16,
Neo (neonate), P8, P15, and ad (adult) refer to ages of whole brain samples; Yt, yeast tRNA. Each experiment described in this ®gure was
repeated a minimum of three times.
tures, and most cells were presumed to be postmitotic based effects of IL7 (Goodwin et al., 1990). The gc subunit, pre-
viously known as the IL2g subunit, was identi®ed as anon their neuritic processes. It is possible that a population
of precursors was induced to proliferate and in turn gave additional subunit of the IL7 receptor (Kondo et al., 1993;
Noguchi et al., 1993; Russell et al., 1993). Like other mem-rise to the increased number of process-containing neurons.
However, there was no detectable change in thymidine in- bers of the hematopoietin receptor superfamily, the IL7 re-
ceptor is not an intrinsic tyrosine kinase, but rather acti-corporation after IL7 treatment of cultured hippocampus
(unpublished observations). Treatment of single cells with vates cytoplasmic tyrosine kinases. Receptor complexes
which contain the gc subunit, including that of IL7, activateIL7 increased survival of neuro®lament-positive cells,
clearly demonstrating an effect on neuronal survival. Fur- kinases of the Janus family, namely Jak1 and Jak3 (Johnston
et al., 1994; Kirken et al., 1994; Miyazaki et al., 1994; Rus-ther, proliferation was never observed in the single cell cul-
tures. These results support earlier ®ndings that IL7 induces sell et al., 1994; Witthuhn et al., 1994). Jak1 is expressed
in vivo in the developing and adult CNS (Yang et al., 1993),immortalized hippocampal progenitor cells to differentiate
into mature neurons (Mehler et al., 1993). and Jak3 is expressed during brain development as well
(M.D.M. and J.A.K., unpublished observations). Addition-The high af®nity IL7R is responsible for mediating the
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ally, in various pre B-cell lines, IL7 has been shown to en- is that described in the study of op/op mice (Michaelson et
al., in press). Such animals do not express functional colonyhance the catalytic activity of certain src family tyrosine
kinases, including p59fyn and p53/56lyn (Venkitaraman and stimulating factor-1 (CSF-1), a growth factor for microglia
and other cells of the macrophage/monocyte lineage, andCowling, 1992; Seckinger and Fougereau, 1994). There is no
evidence that IL7 activates the Jak kinases in neural cells. display grossly normal brain architecture (Chang et al.,
1994). However, novel functional electrophysiologic tech-However, we found that p59fyn is phosphorylated in re-
sponse to IL7 treatment in neurons cultured from cortex niques have now revealed severe developmental de®cits,
including impaired auditory and visual processing, withand is presumably responsible for mediating at least some
of the neurotrophic effects of IL7. The expression of p59fyn in speci®c abnormalities within the neuronal circuitry of the
cerebral cortex (Michaelson et al., in press). Some of theseneurons in developing and adult brain has been previously
demonstrated (Maness, 1992; Bixby and Jhabvala, 1993; functional assays, including laminar pro®les of visual and
somatosensory-evoked potentials, have been applied toUmemori et al., 1992; Bare et al., 1993). Additionally, stud-
ies with p59fyn-de®cient mice have suggested a develop- IL7R 0/0 mice as well, and have thus far failed to demon-
strate signi®cant abnormalities (P. L. Bieri, M.D.M., andmental role for the kinase, in suckling behavior and myelin-
ation (Yang et al., 1993; Umemori et al., 1994). Of particular J.A.K., unpublished observations). However, this functional
in vivo approach offers an entirely new set of experimentalinterest is the ®nding that transgenic mice lacking p59fyn
have signi®cant CNS abnormalities, particularly in the hip- avenues in the mutant animals.
A third approach, in addition to analysis of synaptic pat-pocampus, where long-term potentiation is impaired (Grant
et al., 1992). IL7 and its receptor are expressed in hippocam- terning and in vivo systems electrophysiology, is the cellu-
lar approach taken by Ignelzi et al. in studying neurons frompus as well, both in vivo and in vitro, and we found signi®-
cant trophic effects of IL7 on hippocampal neurons in vitro. mice with mutation of the src gene (Ignelzi et al., 1994).
Although the gross structure of the brains from such ani-It is thus intriguing to speculate upon whether some of
the de®cits observed in animals lacking p59fyn are due to mals is also normal, in vitro studies have revealed that src-
minus cerebellar neurons display impaired neurite out-decreased IL7 input during hippocampal development.
Initial examination of IL7R 0/0 mutant mice has failed growth in a substrate-speci®c manner. This in vitro strategy
could be applied to IL7R mutant animals as well, speci®-to reveal gross anatomic abnormalities in neural develop-
ment (unpublished observations). However, there are now cally looking at the behavior of IL7R-minus neurons cul-
tured from cerebellum, cortex, and hippocampus with re-numerous examples of animals with mutations in trophic
factors, or signal transduction elements, which fail to pro- spect to growth factor response, substrate-speci®c cellular
modulation, and more general patterns of proliferation, sur-duce obvious neural defects. Mutation of any of the neuro-
trophins or of their high-af®nity receptors, while dramati- vival, and differentiation.
To assess whether IL7 exerts short-term regulatory effectscally altering peripheral nervous system development, has
little effect on normal CNS anatomic development (Snider, on neurons which can be observed prior to its long-term
survival effects, we examined expression of three myc fam-1994). Nevertheless, a growing body of literature has impli-
cated the neurotrophins in synaptic plasticity, in both the ily genes in high-density embryonic cultures in which neu-
rons survive well without exogenous trophic factors. Priordeveloping and mature animal (reviewed in Lo, 1995). Syn-
aptic activity at developing synapses can be modi®ed by studies in lymphocytic cell lines have shown that in pre-
B cells, c-myc expression rapidly increases by 10-fold inboth BDNF and NT-3 (Lohof et al., 1995; Kang and Schu-
man, 1995). Infusion of BDNF and NT-4/5 into developing response to IL7 and decreases within a few hours (Morrow
et al., 1992). Similarly, N-myc levels are rapidly increasedvisual cortex prevents the formation of ocular dominance
columns, (Cabelli et al., 1995), and recent evidence demon- by IL7 treatment, but remain elevated for extended periods.
Interestingly, more mature B cells respond to IL7 with anstrates that neurotrophins, particularly BDNF and NT-4,
may modulate layer-speci®c growth of dendrites in devel- increase in c-myc but not N-myc, consistent with a putative
restriction of N-myc to cells at early developmental stagesoping visual cortex (McAllister et al., 1995). Although there
is as yet no evidence supporting a role for IL7 in synapse (DePinho et al., 1991). IL7 has a similar effect on both a T
cell line and primary thymocytes, rapidly increasing c-mycformation, the timing of its expression in multiple areas of
developing brain, combined with increased process out- expression (Seckinger et al., 1994; Yip-Schneider et al.,
1993). N-myc expression is not affected by IL7 in mature Tgrowth in IL7-treated embryonic neurons, suggest this pos-
sibility. Studies examining the effects of exogenous IL7 on cells. We found that IL7 treatment of neuronal cultures
from developing mouse cortex, in doses similar to thosesynapse formation, as well as activity-dependent trophic
function in normal vs IL7R mutant mice, might yield inter- utilized in lymphocytic cultures, induced an increase in c-
myc mRNA within 15 min. Whether the upregulation wasesting results. Transgenic mice which overexpress IL7 have
also been described (Rich et al., 1993; Fisher et al., 1993), due solely to an increase in transcription or to stabilization
of the c-myc mRNA as well (Yip-Schneider et al., 1993) wasand examination of the effects of endogenous IL7 overex-
pression in the CNS on synaptic formation and dendritic not determined. In contrast, neither N-myc nor L-myc was
noticeably affected by IL7 treatment of neuronal cultures.growth might also be of interest.
Another approach toward studying IL7 mutant animals However, the untreated levels of N- and L-myc mRNA were
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Prickett, K. S., Reed, S. G., Goodwin, R., Cosman, D., and Na-relatively high and may have masked any potential regula-
men, A. E. (1989). Murine thymocytes proliferate in direct re-tion by IL7. More than 97% of the cells grown in serum-free
sponse to interleukin-7. Blood 74, 1368±1373.medium were neurons, suggesting that c-myc regulation
DePinho, R. A., Schreiber-Agus, N., and Alt, F. W. (1991). mycoccurred in neurons; however, it is possible that some of
family oncogenes in the development of normal and neoplasticthe effect occurred in the minor population of nonneuronal
cells. Adv. Cancer Res. 57, 1±46.
cells. Fisher, A. G., Burdet, C., LeMeur, M., Haasner, D., Gerber, P., and
In conclusion, we have identi®ed IL7 as a potential neuro- Ceredig, R. (1993). Lymphoproliferative disorders in an IL-7
trophic factor. IL7 is trophic for cells cultured from the transgenic mouse line. Leukemia 7(suppl. 2), S66±68.
developing CNS, including neurons. Additionally, IL7 and Giulian, D., and Baker, T. J. (1986). Characterization of ameboid
its high af®nity IL7R are expressed both in vivo and in vitro microglia isolated from developing mammalian brain. J. Neu-
rosci. 6, 2163±2178.in neural cells during ontogeny. This study suggests that
Goodwin, R. G., Friend, D. J., Ziegler, S. F., Jerzy, R., Falk, B. A.,certain hematopoietic cytokines, whose actions have been
Gimpel, S., Cosman, D., Dower, S. K., March, C. J., Namen,characterized primarily in the immune system, may have
A. E., and Park, L. S. (1990). Cloning of the human and murinewider spectra of activity, and some of these factors may
interleukin-7 receptors: demonstration of a soluble form and ho-function as trophic factors in the developing CNS.
mology to a new receptor superfamily. Cell 60, 941±951.
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